Hyperperfusion Secondary to Middle Cerebral Artery Stenting

Zhen‐Ni Guo,Ge Yang,Hong‐Liang Zhang,Shouchun Wang,Yi Yang
DOI: https://doi.org/10.1017/s031716710001355x
2012-01-01
Abstract:A 55-year-old man presented with recurrent transient episodes of left-sided hemiparesis for one month. Symptoms lasted three to five minutes per time before subsiding to normal. He was referred to our hospital after five episodic attacks. Upon admission, his blood pressure was 110/65 mmHg. T1 and T2 weighted imaging of brain magnetic resonance imaging (MRI) showed no abnormality. Magnetic resonance angiography (MRA) findings were indicative of a severe stenosis in the right middle cerebral artery (MCA). A >70% stenosis in the M1 segment of the right MCA was corroborated by digital subtraction angiography (DSA) (Figure A). The mean cerebral blood flow (CBF) in the cortical territory of the stenotic MCA was evidently lower than that in the corresponding contralateral cortex (31.5 versus 47.1 ml/(100g·min)), as revealed by xenonenhanced computed tomogram (Xe-CT). An intracranial stent (Apollo, Microport Medical Company, Shanghai, China) was placed in the target artery and DSA showed complete revascularization (Figure B). Nine hours after the operation, the patient developed a persistent headache, nausea and intermittent vomiting. His blood pressure was 185/110 mmHg. Hyperperfusion in the cortical territory of the recanalized artery was noted by emergent Xe-CT examination (60.7 ml/(100g·min) in the right cortex versus 45.9 ml/(100g·min) in the left, Figure C and D). Intravenous infusion of Labetalol under continuous blood pressure monitoring was immediately started to control the blood pressure. His blood pressure was then stabilized at about 120/75 mmHg and the symptoms were resolved. With the extensive use of stenting, the detrimental effects of hyperperfusion after carotid artery stenting have attracted wide attention.1,2 Intracranial stenosis is more prevalent in Asia, but limited data in the literature suggest that cerebral hyperperfusion syndrome (CHS) may also arise from MCA stenting.3-6 The pathological etiology of CHS is poorly understood and few reliable measures are available to make an early diagnosis. Although further studies are still needed, Xe-CT appears promising in the early diagnosis and treatment of CHS.
What problem does this paper attempt to address?